[ed note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who shares his non-investing thoughts with Stock Gumshoe readers a couple times a month. He selects his own topics, and his words and opinions are, of course, his own — you can see his previous commentaries […]
Newsletter/trading service that aims to track important trading catalyst dates for biotech stocks, including FDA approvals and submissions and clinical trial data releases. Formerly called BioScience Millionaire.
[Ed note: Following is another installment from our favorite medical scribe, “Doc Gumshoe” (no, he’s not a doctor). We feature Michael’s commentary every couple weeks or so, and his thoughts and words are his own. “Doc” doesn’t pick stocks, but FDA decisions are a huge driver of investment success for pharmaceutical and biotech companies and […]
“Why I’m Ready to Place a $2,450 “Bet” on Your Behalf… “Given what we’ve learned about one tiny drug company – and the documented 82% success rate within the category of drug it’s developed – we think this is the “surest thing” we’ve ever found… “How this ‘wager’ could make you thousands of dollars (or […]